2025-04-17 |
2025-04-16 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
1.000
-0.5%
23,81
14.856 USD
|
1.000
-0.5%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
GV
Geplanter Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
1.000
-1.7%
23,66
9.890 USD
|
1.000
-1.7%
|
23,66
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
1.000
-0.2%
23,81
73.588 USD
|
1.000
-0.2%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
GV
Geplanter Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-1.1%
23,66
58.866 USD
|
1.000
-1.1%
|
23,66
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-0.9%
23,81
47.876 USD
|
1.000
-0.9%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
1.000
-0.2%
23,81
43.924 USD
|
1.000
-0.2%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
1.000
-0.8%
23,81
20.569 USD
|
1.000
-0.8%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-16 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.000
-0.9%
23,81
28.878 USD
|
1.000
-0.9%
|
23,81
|
100.000 USD
|
|
2025-04-17 |
2025-04-15 |
V
Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
1.000
-1.2%
24,04
7.550 USD
|
1.000
-1.2%
|
24,04
|
100.000 USD
|
|
2025-04-10 |
2025-04-09 |
GV
Geplanter Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.000
-3.3%
23,23
109.088 USD
|
1.000
-3.3%
|
23,23
|
100.000 USD
|
|
2025-04-10 |
2025-04-09 |
GV
Geplanter Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
1.000
-9.8%
23,23
65.090 USD
|
1.000
-9.8%
|
23,23
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-1.1%
24,48
2.350 USD
|
1.000
-1.1%
|
24,48
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-1.6%
23,46
3.565 USD
|
1.000
-1.6%
|
23,46
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-0.7%
24,48
37.545 USD
|
1.000
-0.7%
|
24,48
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.000
-1.1%
23,46
56.531 USD
|
1.000
-1.1%
|
23,46
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
1.000
-2.8%
24,48
76.582 USD
|
1.000
-2.8%
|
24,48
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
1.000
-4.2%
23,46
115.314 USD
|
1.000
-4.2%
|
23,46
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.000
-1.6%
24,48
57.345 USD
|
1.000
-1.6%
|
24,48
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.000
-2.5%
23,46
86.344 USD
|
1.000
-2.5%
|
23,46
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
1.000
-0.4%
24,48
68.848 USD
|
1.000
-0.4%
|
24,48
|
100.000 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
4.420
-0.6%
23,46
103.679 USD
|
4.420
-0.6%
|
23,46
|
103.679 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
730
-2.5%
24,48
17.867 USD
|
730
-2.5%
|
24,48
|
17.867 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
1.148
-3.8%
23,46
26.928 USD
|
1.148
-3.8%
|
23,46
|
26.928 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
4.733
-0.4%
24,48
115.840 USD
|
4.733
-0.4%
|
24,48
|
115.840 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.434
-0.6%
23,46
174.378 USD
|
7.434
-0.6%
|
23,46
|
174.378 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
659
-0.5%
24,48
16.129 USD
|
659
-0.5%
|
24,48
|
16.129 USD
|
|
2025-04-10 |
2025-04-08 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
1.036
-0.8%
23,46
24.301 USD
|
1.036
-0.8%
|
23,46
|
24.301 USD
|
|
2025-03-28 |
2025-03-26 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
1.827
-1.7%
27,46
50.177 USD
|
1.827
-1.7%
|
27,46
|
50.177 USD
|
|
2025-03-20 |
2025-03-19 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
7
-0.1%
28,31
198 USD
|
7
-0.1%
|
28,31
|
198 USD
|
|
2025-03-20 |
2025-03-19 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
81
-0.9%
27,85
2.256 USD
|
81
-0.9%
|
27,85
|
2.256 USD
|
|
2025-03-20 |
2025-03-18 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
39
-0.4%
26,95
1.051 USD
|
39
-0.4%
|
26,95
|
1.051 USD
|
|
2025-03-19 |
2025-03-17 |
GV
Geplanter Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
3.496
-2.5%
25,32
88.519 USD
|
3.496
-2.5%
|
25,32
|
88.519 USD
|
|
2025-02-20 |
2025-02-19 |
GV
Geplanter Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
177
-0.0%
30,00
5.310 USD
|
177
-0.0%
|
30,00
|
5.310 USD
|
|
2025-02-20 |
2025-02-19 |
GV
Geplanter Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
96
-0.1%
30,00
2.880 USD
|
96
-0.1%
|
30,00
|
2.880 USD
|
|
2025-02-20 |
2025-02-18 |
GV
Geplanter Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
3.519
-0.5%
30,06
105.764 USD
|
3.519
-0.5%
|
30,06
|
105.764 USD
|
|
2025-02-20 |
2025-02-18 |
GV
Geplanter Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
5.771
-5.2%
30,04
173.377 USD
|
5.771
-5.2%
|
30,04
|
173.377 USD
|
|
2025-02-20 |
2025-02-18 |
GV
Geplanter Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
3.496
-2.4%
29,72
103.901 USD
|
3.496
-2.4%
|
29,72
|
103.901 USD
|
|
2025-02-18 |
2025-02-14 |
GV
Geplanter Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
4.889
-4.2%
30,09
147.088 USD
|
4.889
-4.2%
|
30,09
|
147.088 USD
|
|
2025-02-18 |
2025-02-14 |
GV
Geplanter Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
3.586
-0.5%
30,13
108.039 USD
|
3.586
-0.5%
|
30,13
|
108.039 USD
|
|
2025-02-18 |
2025-02-13 |
GV
Geplanter Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
28.759
-19.8%
30,00
862.770 USD
|
28.759
-19.8%
|
30,00
|
862.770 USD
|
|
2025-02-18 |
2025-02-13 |
GV
Geplanter Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
16.005
-2.1%
30,00
480.152 USD
|
16.005
-2.1%
|
30,00
|
480.152 USD
|
|
2025-02-18 |
2025-02-13 |
GV
Geplanter Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
11.616
-5.1%
29,70
345.001 USD
|
11.616
-5.1%
|
29,70
|
345.001 USD
|
|
2025-02-11 |
2025-02-07 |
GV
Geplanter Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
300
-0.1%
29,52
8.857 USD
|
300
-0.1%
|
29,52
|
8.857 USD
|
|
2025-02-07 |
2025-02-05 |
GV
Geplanter Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
720
-0.3%
29,50
21.241 USD
|
720
-0.3%
|
29,50
|
21.241 USD
|
|
2025-01-31 |
2025-01-29 |
GV
Geplanter Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
500
-0.2%
29,68
14.841 USD
|
500
-0.2%
|
29,68
|
14.841 USD
|
|
2025-01-29 |
2025-01-28 |
GV
Geplanter Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
6.235
-4.1%
28,50
177.698 USD
|
6.235
-4.1%
|
28,50
|
177.698 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.979
-1.3%
28,15
55.710 USD
|
1.979
-1.3%
|
28,15
|
55.710 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
4.577
-2.9%
27,18
124.425 USD
|
4.577
-2.9%
|
27,18
|
124.425 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
1.453
-1.0%
28,15
40.903 USD
|
1.453
-1.0%
|
28,15
|
40.903 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
3.360
-2.2%
27,18
91.341 USD
|
3.360
-2.2%
|
27,18
|
91.341 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.923
-0.6%
28,15
223.036 USD
|
7.923
-0.6%
|
28,15
|
223.036 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
18.325
-1.4%
27,18
498.161 USD
|
18.325
-1.4%
|
27,18
|
498.161 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
3.235
-0.4%
28,15
91.067 USD
|
3.235
-0.4%
|
28,15
|
91.067 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
7.481
-1.0%
27,18
203.369 USD
|
7.481
-1.0%
|
27,18
|
203.369 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
3.527
-1.5%
28,15
99.287 USD
|
3.527
-1.5%
|
28,15
|
99.287 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
8.158
-3.4%
27,18
221.774 USD
|
8.158
-3.4%
|
27,18
|
221.774 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
1.049
-0.9%
28,15
29.530 USD
|
1.049
-0.9%
|
28,15
|
29.530 USD
|
|
2025-01-29 |
2025-01-27 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
2.426
-2.1%
27,18
65.950 USD
|
2.426
-2.1%
|
27,18
|
65.950 USD
|
|
2025-01-27 |
2025-01-24 |
GV
Geplanter Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
127
-0.5%
28,00
3.556 USD
|
127
-0.5%
|
28,00
|
3.556 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
5.827
-3.9%
27,31
159.139 USD
|
5.827
-3.9%
|
27,31
|
159.139 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
8.426
-5.5%
27,31
230.120 USD
|
8.426
-5.5%
|
27,31
|
230.120 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
12.749
-1.7%
27,31
348.184 USD
|
12.749
-1.7%
|
27,31
|
348.184 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
4.720
-4.1%
27,31
128.907 USD
|
4.720
-4.1%
|
27,31
|
128.907 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
21.692
-1.7%
27,31
592.424 USD
|
21.692
-1.7%
|
27,31
|
592.424 USD
|
|
2025-01-22 |
2025-01-21 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
13.873
-5.8%
27,31
378.881 USD
|
13.873
-5.8%
|
27,31
|
378.881 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
1.089
-0.7%
26,98
29.383 USD
|
1.089
-0.7%
|
26,98
|
29.383 USD
|
|
2025-01-17 |
2025-01-15 |
GV
Geplanter Verkauf
|
Hoffman Allison C
General Counsel & Secretary
Führungsperson
|
3.496
-2.2%
26,87
93.938 USD
|
3.496
-2.2%
|
26,87
|
93.938 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
Gandhi Balaji
Chief Financial Officer
Führungsperson
|
836
-0.6%
26,98
22.556 USD
|
836
-0.6%
|
26,98
|
22.556 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
Roberts Evan
Chief Operating Officer
Führungsperson
|
1.785
-0.2%
26,98
48.162 USD
|
1.785
-0.2%
|
26,98
|
48.162 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
VanDuyn Amy Beth
SVP, Human Resources
Führungsperson
|
604
-0.5%
26,98
16.297 USD
|
604
-0.5%
|
26,98
|
16.297 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
Linetsky David
SVP, Life Sciences
Führungsperson
|
1.946
-0.8%
26,98
52.506 USD
|
1.946
-0.8%
|
26,98
|
52.506 USD
|
|
2025-01-17 |
2025-01-15 |
V
Verkauf
|
Indig Chaim
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
2.990
-0.2%
26,98
80.674 USD
|
2.990
-0.2%
|
26,98
|
80.674 USD
|
|
2025-01-17 |
2025-01-15 |
GV
Geplanter Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
381
-1.5%
26,87
10.237 USD
|
381
-1.5%
|
26,87
|
10.237 USD
|
|
2025-01-16 |
2025-01-14 |
V
Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
362
-1.4%
26,38
9.548 USD
|
362
-1.4%
|
26,38
|
9.548 USD
|
|
2025-01-13 |
2025-01-10 |
GV
Geplanter Verkauf
|
Hui Yvonne
Principal Accounting Officer
Führungsperson
|
388
-1.4%
27,85
10.806 USD
|
388
-1.4%
|
27,85
|
10.806 USD
|
|